| URL: | http://SynMICdb.dkfz.de |
| Full name: | A pan-cancer analysis of synonymous mutations |
| Description: | SynMICdb aims to facilitate the study of synonymous mutations in cancer. These mutations alter the nucleotide sequence of the gene and the mRNA, but not the amino acid sequence of the respective protein. Synonymous mutations can change mRNA structure, stability, splicing, translation efficiency or impact cis-regulatory sequences. These mutations can be recurrent and conserved and mirror many aspects of cancer driving mutations. |
| Year founded: | 2019 |
| Last update: | |
| Version: | |
| Accessibility: |
Accessible
|
| Country/Region: | Germany |
| Data type: | |
| Data object: | |
| Database category: | |
| Major species: | |
| Keywords: |
| University/Institution: | University of Freiburg |
| Address: | Division of Cancer Research, Department of Thoracic Surgery, Medical Center, University of Freiburg, 79085 Freiburg, Germany |
| City: | |
| Province/State: | |
| Country/Region: | Germany |
| Contact name (PI/Team): | Sven Diederichs |
| Contact email (PI/Helpdesk): | s.diederichs@dkfz.de |
|
A pan-cancer analysis of synonymous mutations. [PMID: 31189880]
Synonymous mutations have been viewed as silent mutations, since they only affect the DNA and mRNA, but not the amino acid sequence of the resulting protein. Nonetheless, recent studies suggest their significant impact on splicing, RNA stability, RNA folding, translation or co-translational protein folding. Hence, we compile 659194 synonymous mutations found in human cancer and characterize their properties. We provide the user-friendly, comprehensive resource for synonymous mutations in cancer, SynMICdb ( http://SynMICdb.dkfz.de ), which also contains orthogonal information about gene annotation, recurrence, mutation loads, cancer association, conservation, alternative events, impact on mRNA structure and a SynMICdb score. Notably, synonymous and missense mutations are depleted at the 5'-end of the coding sequence as well as at the ends of internal exons independent of mutational signatures. For patient-derived synonymous mutations in the oncogene KRAS, we indicate that single point mutations can have a relevant impact on expression as well as on mRNA secondary structure. |